Search clinical trials for: thromboembolic risk

Total 15697 results

Universidad Pública de Navarra
Sociedad Española De Medicina Interna; Daiichi Sankyo

Recruiting

Thromboembolic Risk Assessment in Patients Admitted With Acute Medical Diseases to Conventional and At Home Hospitalization (TROMBODOM)

Atrial Fibrillation | Physical Inactivity | Thromboprophylaxis | Thromboembolism, Venous | Hospital at Home

Spain
Institut Cancerologie de l'Ouest
Diagnostica Stago

Recruiting

Thrombin Generation and Prediction of Thromboembolic Events in Oncology Patients at Risk (THROMBIN)

Solid Carcinoma

France
Centre Hospitalier Eure-Seine

Not yet recruiting

Impact of Remote Care in Patients Diagnosed With Thromboembolic Disease of Low Risk (TEVEDOM)

Thromboembolic Disease
Azienda Ospedaliero Universitaria Maggiore della...
Abbott Medical Devices

Recruiting

Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study (ARMYDA-AMULET)

Left Atrial Appendage Occlusion | Antiplatelet Therapy

Italy
Novartis Pharmaceuticals

Recruiting

Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera (Prospero)

Polycythemia Vera

Italy
Qianfoshan Hospital

Not yet recruiting

Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients

Venous Thromboembolic Disease

China
Anthos Therapeutics, Inc.
CYTE Global

Recruiting

Study in Atrial Fibrillation (AF) Patients at High Risk of Stroke (GARDENIA)

Atrial Fibrillation

United States, Czechia, Poland, Spain, Germany, Canada, Hungary, United Kingdom, Argentina, Italy, Brazil, Mexico
Imperial College London
University of Edinburgh; Universidad de Granada

Recruiting

Examining the Benefit of Graduated Compression Stockings in the Prevention of vEnous Thromboembolism in Low-risk Surgical Patients (PETS)

Venous Thromboembolism

United Kingdom
University Hospital, Strasbourg, France

Recruiting

Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin (ENOX-VTD-H)

Venous Thromboembolic Disease

France
University Hospital of Ferrara

Recruiting

Management of Anticoagulants and Antithrombotics in Patients With CSDH (THERCA)

Anticoagulant-induced Bleeding | Chronic Subdural Hematoma | Thromboembolic Stroke | Cardiovascular Stroke

Italy
Brigham and Women's Hospital
Bristol-Myers Squibb; University of Colorado, Denver; Beth Israel Deaconess Medical... and other collaborators

Recruiting

COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications (CORONA-VTE NET)

Myocardial Infarction | Stroke | Covid19 | Pulmonary Embolism | DVT | Thrombosis Embolism

United States
China-Japan Friendship Hospital

Not yet recruiting

CHIPs-VTE Study in Hospitalized Patients With Lung Cancer

Pulmonary Embolism | Deep Venous Thrombosis | Venous Thromboembolic Disease
Saint Antoine University Hospital

Recruiting

Thromboembolic and Bleeding Risk Stratification in Patients With Non-valvular Atrial Fibrillation (FASTRHAC)

Atrial Fibrillation

France
University of Turku

Active, not recruiting

Atrial Fibrillation Burden and Long-term Risk of Thromboembolic Complications- the FinCV-4 Study (FinCV-4)

Atrial Fibrillation | Stroke, Ischemic

Finland
Medical University of Warsaw
National Science Center, Poland

Completed

GDF-15 Levels in Risk Stratification in Acute Pulmonary Embolism

Pulmonary Embolism

Poland
University Hospital, Angers
Poitiers University Hospital; Hôpital Cochin; University Hospital, Grenoble; Cliniques... and other collaborators

Completed

Thromboembolic Risk Stratification by TRiP(Cast) Score to Guide Physicians in Preventive Treatment Prescriptions for Patients With Lower Limb Trauma Requiring Brace or castING. (CASTING)

Venous Thromboembolism | Lower Limb Trauma | Stratification

France, Belgium
Hopital Foch
University Hospital, Brest; Hospital Ambroise Paré Paris

Completed

Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease (COVIDEP)

Pneumonia, Viral

France
Daiichi Sankyo, Inc.

Completed

Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease

Cardiac Disease

United States, Spain, Canada, Lebanon, Turkey, Austria, Croatia, Egypt, France, Hungary, India, Israel, Ukraine, United Kingdom
Andres muñoz
Hospital Clinic of Barcelona; LEO Pharma; Hospital General Universitario Elche; Hospital Universitario Ramon y Cajal and other collaborators

Completed

A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient (ONCOTHROMB)

Genetic Predisposition | Cancer-associated Thrombosis

Spain
Centre Antoine Lacassagne

Completed

Thromboembolic Risk Screening in Patients With Cancer and COVID-19 (NEOTHROCOVID)

Covid19 | Thromboembolism | Neoplasms Malignant

France, Monaco
CSL Behring
Kaiser Permanente

Completed

An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding

Hemorrhage

United States
iPHNET (italian Pulmonary Hypertension NETwork)

Unknown

CTEPH in Patients With Prior Pulmonary Embolism and Risk Score Validation (CTEPH-SOLUTION)

Pulmonary Embolism | Chronic Thromboembolic Pulmonary Hypertension

Italy
Assistance Publique - Hôpitaux de Paris

Unknown

Evaluation of NETs in Patients With Solid Cancers Associated With a High Risk of Venous Thromboembolic Events (Flownet)

Gastric Cancer | Colorectal Cancer | Pancreatic Cancer

France
Chiesa Alessandro Felice

Completed

Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19

SARS Virus

Switzerland
Nisantasi University

Completed

Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia (Covid-19)

Corona Virus Infection | Thromboembolic Disease

Turkey
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Venous Thromboembolism and Bleeding Risk in Patients With Esophageal Cancer (VENETIA)

Bleeding | Venous Thromboembolism | Chemotherapy Effect | Esophagus Cancer

Netherlands
University Hospital, Brest

Unknown

Development of a Model to Predict the Risk of Venous Thromboembolic Events in Patients With Metastatic Bronchopulmonary Cancer (LUCAAT)

Metastatic Bronchopulmonary Cancer

France
Janssen Research & Development, LLC
Bayer

Completed

A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients (MARINER)

Heart Failure | Rheumatic Diseases | Respiratory Insufficiency | Infectious Diseases | Stroke Acute

United States, Poland, Ukraine, United Kingdom, Germany, Spain, Argentina, Belarus, Colombia, Israel, Mexico, Portugal, Bulgaria, Romania, Serbia, South Africa, Turkey, Canada, Australia, Netherlands, Denmark, Greece, Peru, Brazil, Russian... and more
Texas Cardiac Arrhythmia Research Foundation

Unknown

Association of Genetic Variants With Risk of Stroke in Patients With Atrial Fibrillation Off-anticoagulation (GSAF)

Thromboembolic Events

United States
Ottawa Heart Institute Research Corporation
Bristol-Myers Squibb; Bayer; Boehringer Ingelheim; Heart and Stroke Foundation...

Completed

Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events (BRUISECONTROL2)

Hematoma

Canada, Israel
Mark W. Dodson

Unknown

The Prospective Risk Factor Evaluation & Discovery In CTEPH Study (PREDICT PH)

Chronic Thromboembolic Pulmonary Hypertension

United States
University Hospital, Brest

Unknown

Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure (FIT-H)

Venous Thromboembolic Disease

France
University Hospital, Geneva
University Medical Center Groningen; The Ottawa Hospital

Unknown

Age-adjusted D-dimer Cutoff Levels to Rule Out Deep Vein Thrombosis: a Prospective Outcome Study (ADJUST-DVT)

Deep Vein Thrombosis | D-dimer

Canada, Switzerland, France
Chinese Academy of Medical Sciences, Fuwai Hospital

Unknown

Registry for Pulmonary Hypertension in China

Death | Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary Hypertension

China
Institut de Cancérologie de la Loire

Completed

Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study (ONCOCIP)

Cancer

France
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients (MAGELLAN)

Venous Thromboembolism

Belgium, France, Norway, Spain, China, Taiwan, United States, Switzerland, Colombia, Canada, Estonia, New Zealand, Finland, Italy, Portugal, Japan, Singapore, Germany, Greece, Australia, Sweden, Austria, Chile, Slovakia, United Kingdom, M... and more
GlaxoSmithKline
Sanofi

Completed

A Study to Evaluate the Efficacy and Safety of Fondaparinux Sodium When Used With Intermittent Pneumatic Compression to Prevent Venous Thromboembolic (IPC) Versus IPC Alone for the Prevention of Venous Thromboembolic Events in Subjects at Increased Risk Undergoing Major Abdominal Surgery (APOLLO).

Thromboembolism
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Impact of Decision Aids to Enhance Shared Decision Making for Diabetes (DAD)

Diabetes

United States
Kerckhoff Klinik
Hannover Medical School; University Hospital, Saarland

Unknown

Prospective Registry to Evaluate the Effective Incidence of Chronic Thromboembolic Pulmonary Hypertension in Germany

Chronic Thromboembolic Pulmonary Hypertension | CTEPH

Germany
Sanofi
Bristol-Myers Squibb

Completed

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)

Atrial Fibrillation | Vascular Risk

United States, France, Canada, Brazil, Poland, Australia, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, Malaysia, Singapore, Taiwan, Belgium, Czech Republic, Mexico, Argentina, Denmark, Finland, Hungary, Norway, United... and more
Ural State Medical University
Ural Institute of Cardiology; De Haar Research Foundation

Terminated

Ranibizumab and the Risk of Arterial Thromboembolic Events (RATE)

Coronary Artery Disease | Cerebrovascular Disorders | Age-related Macular Degeneration

Netherlands, Russian Federation
Korea University

Unknown

Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk

Atrial Fibrillation | Thromboembolism
Ottawa Hospital Research Institute
LEO Pharma

Completed

A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery

Hemodialysis | Thromboembolism

Canada
Uppsala University

Completed

RElevance of Biomarkers for Future Risk of Thromboembolic Events in UnSelected Post-myocardial Infarction Patients (REBUS)

Myocardial Infarction

Sweden
University Hospital, Geneva
Sanofi; University of Zurich; University Hospital Inselspital, Berne; Luzerner... and other collaborators

Completed

Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland

Venous Thromboembolism

Switzerland
Comitato Etico di Area Vasta Sud Est
Carla Caffarelli

Completed

Long Term Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols and Berberine) in Low-moderate Risk Hypercholesterolemic Patients: a Double-blind, Placebo Controlled Study

Hypercholesterolemia
Air Force Military Medical University, China

Unknown

Epidemiological Study of Chronic Thromboembolic Pulmonary Hypertension in China

To Assess the Long-term Risk for Adverse Events After PE.

China
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Completed

Predictive Factors for Major Bleeding Risk in Patients Admitted in a Palliative Care Unit (RHESO)

Hemorrhage

France
University of Zurich

Completed

Smoking: a Risk Factor for Pulmonary Arterial Hypertension? (DACH)

Pulmonary Hypertension

Switzerland, Germany, Austria
Centre Hospitalier Universitaire de Saint Etienne
ARGOS; Association de la Vallée de l'Ondaine

Completed

Prediction of the Risk of Placental Vascular Pathology and Venous Thromboembolic Disease (AngioPred)

Placental Vascular Pathologies | Venous Thromboembolism Diseases

France

Search clinical trials for: thromboembolic risk

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations